SCHEMBL7974505

SCHEMBL7974505

O=c1[nH]c(-c2ccc(F)cc2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ KMT2A Q03164 2/20 0.54
▸ HPGD P15428 1/20 0.53
▸ TNKS O95271 1/20 0.48
▸ TNKS2 Q9H2K2 1/20 0.48
▸ PARP2 Q9UGN5 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PNP P00491 2/20 0.43
▸ PARN O95453 1/20 0.43
▸ CNOT7 Q9UIV1 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ ACP1 P24666 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ PLEC Q15149 1/20 0.41
▸ MET P08581 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986518 0.95 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7984279 0.94 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7975265 0.92 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7988635 0.90 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7975129 0.89 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7984453 0.89 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7988814 0.89 MAPK1 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDL3MBTL1
SCHEMBL7973869 0.89 TNKS (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
SCHEMBL7985164 0.89 KMT2A (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS
Hydrochloric Acid SCHEMBL7985511 0.88 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KMT2AHPGDTNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback